• Skip to primary navigation
  • Skip to main content
DB-I Logo

DenseBreast-info, Inc.

Get Smart About Being Dense

HOME/USA

EUROPE

Español

  • Home
  • For Patients
    • Patients Home
    • Dense Breasts: 5 Facts You Should Know
    • Is My Mammogram Enough?
    • Screening Tests After a Mammogram (Table)
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Questions and Answers
    • Patient Resources by Language
    • Print: Patient Fact Sheet
    • Print: Patient Brochure
  • For Providers
    • Providers Home
    • CME/CE: “Dense Breasts, Risk, and Supplemental Screening”
    • Flow Chart: Who Needs More Screening?
    • Health Care Provider FAQs
    • Risk Model Tutorial
    • Table: Mammography Guideline Comparison
    • Table: Dense Breast Screening Guidelines
    • Table: High/Increased-Risk Screening Guidelines
    • DBI Research
    • Patient Resources
  • Screening Technologies
    • Screening Technologies Home
    • For Patients: Screening Tests After a Mammogram (Table)
    • For Providers: Cancer Detection by Screening Method (Table)
    • 2D/3D Mammography
    • Mammography AI Screening Tools, Comparative Tables
    • Breast Ultrasound (Sonogram)
    • Breast MRI
    • Contrast-Enhanced Mammography (CEM)
    • Molecular Breast Imaging
    • DBI Research
  • Inform/Insurance Laws
    • Inform/Insurance Laws Home
    • Inform: Federal FDA Dense Breast Reporting
    • Insurance
      • State Law Insurance Map and Federal HRSA Guidelines
      • State Law Insurance Table
      • Federal Insurance Bill: Find It Early Act
  • Blog & Press
  • About Us
    • About Us Home
    • Our Mission
    • World Dense Breast Day
    • Our Team
    • DBI Research
    • Let’s Talk About Dense Breasts, Video Series
    • Patient Resources
    • Contact Us
    • Please Donate
  • Our Corporate and Health Group Supporters
/ Blog / Are Breast Cancers Diagnosed Soon After a Normal Mammogram More Aggressive?
Are Breast Cancers Diagnosed Soon After a Normal Mammogram More Aggressive? | Dense Breast Info

Are Breast Cancers Diagnosed Soon After a Normal Mammogram More Aggressive?

November 16, 2026 by Dense Breast Info

An interval breast cancer is diagnosed after a mammogram that did not identify cancer but before the next routine screening and are considered screen failures. These cancers may have been hidden on the original mammogram or developed between screenings. Understanding why interval cancers develop and how they behave is vital for refining screening schedules. 

Clinical guidelines differ regarding screening frequency. Major medical organizations recommend either annual mammograms starting at age 40 or 45, or biennial screening every two years starting at age 40. These conflicting recommendations leave women and physicians uncertain about optimal screening intervals, particularly for women with dense breast tissue. 

Study Description 

In this study, researchers investigated whether cancers diagnosed within the first year after BI-RADS 1, 2, or 3 assessments on screening mammography differed from those diagnosed during the second year, particularly in women with dense breasts.  Interval cancers included those detected because of symptoms but some have been detected by supplemental screening MRI or ultrasound, though details of supplemental screening were not provided. 

Researchers conducted a retrospective study using linked records from the Utah Population Database, Utah Cancer Registry, and two major healthcare systems. The study evaluated 149,769 women aged 38 to 79 receiving screening mammograms between 2005 and 2019. Researchers identified 2,122 women diagnosed with interval breast cancer within 24 months of a normal mammogram. They compared cancers diagnosed >1 to 12 months (early interval cancer) with those diagnosed at 13 to <24 months, with respect to breast density, age, tumor size, stage, lymph node involvement, and molecular subtype. 

Key Findings 

  • Early interval cancers had more aggressive biological features than those detected in the second year after a clear mammogram.¹ 
  • Early interval cancer were significantly more likely to have spread to nearby lymph nodes or distant organs.² 
  • Aggressive cancer subtypes, including HER2-positive and triple-negative breast cancers, were far more frequent in early interval cases.³ 
  • Women under age 70 had a higher likelihood of developing an early interval cancer compared to older women.⁴ 
  • Extremely dense breasts doubled the likelihood that an interval cancer appear within the first 12 months rather than the second.⁵ 

 

Interpretation/Implications 

Based on the results, the authors recommend annual rather than biennial mammography for women younger than 70 or with dense breasts. The authors recommend women with dense breasts should also discuss supplemental screening with MRI or ultrasound. 

Limitations 

The predominantly White Utah population limits generalizability, and it was not detailed how many interval cancers were found on supplemental screening vs. because of symptoms. Future prospective studies in broader populations are needed. 

Detailed Results 

1 Early interval cancers (>1–12 months) comprised 22.9% of cases (486/2,122), while late interval cancers (13–<24 months) comprised 77.1% (1,636/2,122); early cases presented with larger tumor size (>20 mm in 39.1% vs 20.2%) and higher grade. 

2 Compared to late interval cancers, early interval cancers showed higher odds of axillary node metastasis (OR = 1.68, 95% CI: 1.29–2.19, P < 0.01) and distant stage IV metastatic disease (OR = 4.07, 95% CI: 2.03–8.29, P < 0.01) at diagnosis. 

3 Women with early interval cancers had increased odds of HER2-positive tumors (OR = 2.10, 95% CI: 1.36–3.22, P < 0.01) and triple-negative tumors (OR = 2.08, 95% CI: 1.26–3.39, P < 0.01) compared to 13–24-month cases. 

4 Younger age was strongly associated with early interval cancer: age 38–49 years had an OR of 2.34 (95% CI: 1.61–3.40), age 50–59 had an OR of 1.88 (95% CI: 1.37–2.59), and age 60–69 had an OR of 1.67 (95% CI: 1.23–2.27) compared to age 70–79 (all P < 0.01). 

5 Women with extremely dense breasts at index screening had twice the odds of developing early interval cancer compared to those with fatty breasts (OR = 2.05, 95% CI: 1.13–3.80, P = 0.02). 

DenseBreast‑info, Inc. is an independent, nonprofit organization. DBI is not affiliated with or endorsed by other organizations unless expressly identified. If you have questions about DBI’s programs or partnerships, please contact us.

© Unpublished, DenseBreast-info, Inc. ALL RIGHTS RESERVED | 501(c)(3) Public Charity

  • Online Privacy Policy
  • Online Terms of Use & Disclaimers

This website is for informational purposes only and is not intended to be a substitute for medical advice from a physician or to create a standard of care for health care providers. In addition, information has been provided by independent third parties and may not represent the views of DenseBreast-info.org. Please check with a physician regarding your specific condition, if you have any questions, or need a diagnosis. If you are experiencing an urgent medical condition, call your local emergency services [e.g., 9-1-1 (in the USA) or 1-1-2 (in Europe)].